No Data
No Data
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
Earnings Preview: MLYS to Report Financial Results Post-market on May 12
$Mineralys Therapeutics(MLYS.US)$ is scheduled to release its financial results post-market on May 12 ET. Earnings PreviewAnalysts estimate $Mineralys Therapeutics(MLYS.US)$ to post revenue of USD0.00
Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025
Mineralys Therapeutics(MLYS.US) 10% Shareholder Buys US$3.5 Million in Common Stock
$Mineralys Therapeutics(MLYS.US)$ 10% Shareholder Slingsby Brian Taylor purchased 259.26K shares of common stock on Mar 13, 2025 at an average price of $13.5 for a total value of $3.5 million. This
Mineralys Therapeutics Reveals Publication Of Pivotal Phase 2 Advance-HTN Results In The New England Journal Of Medicine
Mineralys Therapeutics Announces Publication of Pivotal Phase 2 Advance-HTN Results in the New England Journal of Medicine (NEJM)